| ACE | Angiotensin converting enzyme |
| AKI | Acute kidney injury |
| ARB | Angiotensin receptor blocker |
| ARDS | Acute respiratory distress syndrome |
| CI | Confidence intervals |
| CLD | Chronic liver disease |
| COPD | Chronic obstructive pulmonary disease |
| COVID-19 | Coronavirus disease 2019 |
| CKD | Chronic kidney disease |
| DM | Diabetes mellitus |
| eGFR | Estimated glomerular filtration rate |
| ESRD | End-stage renal disease |
| ICU | Intensive care unit |
| HD | Hemodialysis |
| MERS-COV | Middle East respiratory syndrome coronavirus |
| OR | Odds ratio |
| PCR | Polymerase chain reaction |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| RAAS | Renin–angiotensin–aldosterone system |
| RR | Relative risk |
| RRT | Renal replacement therapy |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus-2 |